We are live on ! Find out more
HGEN

HUMANIGEN, INC.

Delisted

HGEN was delisted on the 25th of July, 2023.

92 hedge funds and large institutions have $448M invested in HUMANIGEN, INC. in 2021 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 24 increasing their positions, 21 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

111% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 18

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

28% more funds holding

Funds holding: 7292 (+20)

14% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 21

4% more capital invested

Capital invested by funds: $430M → $448M (+$18.1M)

34% less call options, than puts

Call options by funds: $14.2M | Put options by funds: $21.5M

Holders
92
Holders Change
+20
Holders Change %
+27.78%
% of All Funds
1.6%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
38
Increased
24
Reduced
21
Closed
18
Calls
$14.2M
Puts
$21.5M
Net Calls
-$7.29M
Net Calls Change
-$13M
Name Holding Trade Value Shares
Change
Change in
Stake
HAG
101
HighPoint Advisor Group
Illinois
-$300K -17,400 Closed
Capstone Investment Advisors
102
Capstone Investment Advisors
New York
-$316K -16,521 Closed
HT
103
HAP Trading
New York
-$302K -15,812 Closed
Balyasny Asset Management
104
Balyasny Asset Management
Illinois
-$217K -11,362 Closed
Pacer Advisors
105
Pacer Advisors
Pennsylvania
-$93K -4,850 Closed
CAC
106
Cowen and Company
New York
-$40K -2,097 Closed
MS
107
Maven Securities
Jersey
-$34K -1,777 Closed
WP
108
WealthShield Partners
North Carolina
-$12K -71 Closed
Fidelity Investments
109
Fidelity Investments
Massachusetts
+$18 +1 New

HGEN Hedge Fund Activity: Q2 2021 in Review

92 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in HUMANIGEN, INC. (HGEN) for Q2 2021, worth a combined $448M — up 4.2% from $430M a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new HGEN positions and 18 closed out — a net gain of 20 holders — while 24 added to existing stakes and 21 trimmed.

The largest buyer was BlackRock, adding an estimated $40.9M. The largest seller was Anson Funds Management, exiting entirely with an estimated $13.4M sold.

  • 92 institutional investors held HUMANIGEN, INC. (HGEN) as of Q2 2021, up from 72 in Q1 2021.
  • Funds reported $448M of HUMANIGEN, INC. stock for Q2 2021, up 4.2% quarter-over-quarter.
  • 38 funds opened new HUMANIGEN, INC. positions in Q2 2021 and 18 closed out, a net change of +20 holders.
  • The largest HUMANIGEN, INC. buyer in Q2 2021 was BlackRock, an estimated $40.9M added.
  • The largest HUMANIGEN, INC. seller in Q2 2021 was Anson Funds Management, an estimated $13.4M sold.

Based on aggregated 13F filings for Q2 2021.